Syneos Health (NASDAQ:SYNH) reported Q4 EPS of $1.23, $0.02 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.36 billion versus the consensus estimate of $1.29 billion.
GUIDANCE:
Syneos Health sees Q1 2023 EPS of $3.26-$3.53, versus the consensus of $3.89. ObsEva SA sees Q1 2023 revenue of $4.975-5.175 billion, versus the consensus of $5.13 billion.